Patents by Inventor Shixiang Cheng

Shixiang Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11946073
    Abstract: A method for non-enzymatic 3D culture and amplification of mesenchymal stem cells (MSCs) includes the followings steps: preparing PLGA porous microspheres; preparing a PLGA-PEG-PLGA thermosensitive coating microcarrier; culturing and amplifying MSCs; and performing non-enzymatic separation of MSCs, including reducing a culture temperature to below a critical phase transition temperature, and centrifuging a culture medium to collect stem cells. The present invention adopts the method for non-enzymatic 3D culture and amplification of MSCs, wherein the PLGA porous microspheres are used as a cell culture microcarrier scaffold and the thermosensitive hydrogel PLGA-PEG-PLGA is coated on surfaces of such microspheres, without needing additional enzymolysis process, thus efficiently amplifying the stem cells.
    Type: Grant
    Filed: May 8, 2022
    Date of Patent: April 2, 2024
    Assignees: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) Limited
    Inventors: Bin Zheng, Yulin Cao, Wenchang Peng, Shixiang Cheng
  • Publication number: 20240091282
    Abstract: A probiotic microcapsule for the treatment of reproductive tract infection and a preparation method and application thereof are provided. The probiotic microcapsule is obtained by coating probiotics with the coating material. The probiotics include one or several of Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus fermentum, Lactobacillus reuteri, Lactobacillus crimpus, Lactobacillus brevis, Lactobacillus salivary, Lactobacillus plantarum, Lactobacillus acidophilus, and Lactobacillus bulgaricus. As probiotics screened in reproductive tract, it has high safety; It endows probiotics with adhesion function to ensure their effect in the reproductive tract; It overcomes the defects of current antibiotic therapy; It is expected to be used in a variety of reproductive tract infectious diseases.
    Type: Application
    Filed: October 18, 2022
    Publication date: March 21, 2024
    Applicants: Tangyi Biomedical (Tianjin) Co., Ltd., Tangyi Holding (Shenzhen) Co., Ltd.
    Inventors: Bin ZHENG, Qinglu GUO, Yulin CAO, Shixiang CHENG, Zhihui BAI
  • Publication number: 20240091514
    Abstract: A transdermal double-layer microneedle based on hydrogen producing probiotics and its preparation method and application thereof are provided. The transdermal double-layer microneedle consists of a needle body and a backing layer. The raw material of the needle body includes hyaluronic acid and hyaluronidase. The raw material of the backing layer includes methacrylate anhydride gelatin and silk fibroin protein. The hydrogen producing bacteria are loaded in the microneedles, and the pore size of the matrix material is lower than the diameter of the probiotics, which will not lead to the leakage of bacteria and has high safety. Treatment of inflammatory skin diseases by gas has low side effects. The needle tip is loaded with hyaluronidase to increase the tissue space and improve the effect of gas treatment. It is expected to be used in psoriasis and other inflammatory skin diseases.
    Type: Application
    Filed: October 18, 2022
    Publication date: March 21, 2024
    Applicants: Tangyi Biomedical (Tianjin) Co., Ltd., Tangyi Holding (Shenzhen) Co., Ltd.
    Inventors: Bin ZHENG, Qinglu GUO, Yulin CAO, Shixiang CHENG, Zhihui BAI
  • Patent number: 11826461
    Abstract: The present invention discloses a nano-armored single cell product, comprising a liposome and probiotics encapsulated by the liposome, wherein the probiotics are fermented to produce gamma-aminobutyric acid (GABA) that alleviates the activation of an inflammatory response in substantia nigra inducedin a MPTP induced PD model, thus mitigating an inflammatory injury to dopaminergic neurons in substantia nigra and having a neuroprotective effect; encapsulation of the probiotics by the liposome can protect the probiotics from strong acids and digestive enzymes in gastric acid.
    Type: Grant
    Filed: October 18, 2021
    Date of Patent: November 28, 2023
    Assignees: TANGYI HOLDINGS (SHENZHEN) LIMITED, HEALTHINA STEM CELL INDUSTRY PLATFORM (TIANJIN) LIMITED
    Inventors: Bin Zheng, Yulin Cao, Bowen Li, Wei Sun, Shixiang Cheng
  • Patent number: 11793840
    Abstract: The present invention discloses a nano-armored single cell product, comprising a liposome and probiotics encapsulated by the liposome, wherein the probiotics are fermented to produce gamma-aminobutyric acid (GABA) that alleviates the activation of an inflammatory response in substantia nigra inducedin a MPTP induced PD model, thus mitigating an inflammatory injury to dopaminergic neurons in substantia nigra and having a neuroprotective effect; encapsulation of the probiotics by the liposome can protect the probiotics from strong acids and digestive enzymes in gastric acid.
    Type: Grant
    Filed: October 18, 2021
    Date of Patent: October 24, 2023
    Assignees: Tangyi Holdings(Shenzhen) Limited, Healthina Stem Cell Industry Platform (Tianjin) Limited
    Inventors: Bin Zheng, Yulin Cao, Wei Sun, Qinglu Guo, Shixiang Cheng
  • Publication number: 20230287352
    Abstract: A method for non-enzymatic 3D culture and amplification of mesenchymal stem cells (MSCs) includes the followings steps: preparing PLGA porous microspheres; preparing a PLGA-PEG-PLGA thermosensitive coating microcarrier; culturing and amplifying MSCs; and performing non-enzymatic separation of MSCs, including reducing a culture temperature to below a critical phase transition temperature, and centrifuging a culture medium to collect stem cells. The present invention adopts the method for non-enzymatic 3D culture and amplification of MSCs, wherein the PLGA porous microspheres are used as a cell culture microcarrier scaffold and the thermosensitive hydrogel PLGA-PEG-PLGA is coated on surfaces of such microspheres, without needing additional enzymolysis process, thus efficiently amplifying the stem cells.
    Type: Application
    Filed: May 8, 2022
    Publication date: September 14, 2023
    Applicants: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) Limited
    Inventors: Bin ZHENG, Yulin CAO, Wenchang PENG, Shixiang CHENG
  • Publication number: 20230277827
    Abstract: A recombinant subunit vaccine microneedle product includes a backing and a recombinant subunit lung-associated virus vaccine solution-containing microneedle array attached to a side of the backing, wherein the recombinant subunit lung-associated virus vaccine solution-containing microneedle array includes a plurality of microneedles, wherein each microneedle contains a matrix and a recombinant subunit loaded in the matrix. The present invention adopts the recombinant subunit vaccine microneedle product as well as a preparation method and an application thereof, wherein such microneedle product can realize a rapid humoral immunity after being administered to the skins of animal bodies (especially human bodies), which solves the problems of traditional lung-associated virus vaccine injection, such as muscular pain and multiple injections.
    Type: Application
    Filed: May 24, 2022
    Publication date: September 7, 2023
    Applicants: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) Limited
    Inventors: Bin ZHENG, Yulin CAO, Wei SUN, Shixiang CHENG
  • Publication number: 20230277825
    Abstract: An mRNA vaccine microneedle product includes a backing and a mRNA vaccine solution-containing microneedle array attached to a side of the backing, wherein the mRNA solution-containing microneedle array includes several microneedles, and each microneedle contains a matrix and mRNA loaded in the matrix. The present invention adopts the mRNA vaccine microneedle product as well as a preparation method and an application thereof, and such microneedle product can realize a rapid humoral immunity after being administered to the skins of animal bodies (especially human bodies), which solves the problems of traditional vaccination, such as muscular pain and multiple injections.
    Type: Application
    Filed: May 13, 2022
    Publication date: September 7, 2023
    Applicants: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings (Shenzhen) Limited
    Inventors: Bin ZHENG, Yulin CAO, Wei SUN, Shixiang CHENG
  • Publication number: 20230277826
    Abstract: An inactivated virus vaccine microneedle product includes a backing and an inactivated virus-containing microneedle array attached to a side of the backing, wherein the inactivated virus-containing microneedle array includes a plurality of microneedles, and each microneedle contains a matrix and an inactivated virus loaded in the matrix. The present invention adopts the inactivated virus vaccine microneedle product as well as a preparation method and an application thereof, and such microneedle product realizes efficient transdermal absorption of a vaccine by loading an inactivated virus in the microneedle product after being administered to the skin, and a long-acting stable release of a vaccine is achieved, which solves the problems of traditional vaccination, such as muscular pain and multiple injections.
    Type: Application
    Filed: May 21, 2022
    Publication date: September 7, 2023
    Applicants: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) Limited
    Inventors: Bin ZHENG, Yulin CAO, Wei SUN, Shixiang CHENG
  • Publication number: 20230272426
    Abstract: The method of preparing polyethyleneimine-lipid nanoparticles (PEI-LNPs) for transfecting stem cells includes the following steps: S1, adding anhydride to a PEI solution to produce polycarboxylic acid; S2, dissolving the PEI-LNPs from S1, together with DPPC, DPPG, DPPE-PEG-COOH and cholesterol in chloroform, dissolving cGAMP in a water and then adding to such chloroform solution, and performing vacuum evaporation to remove the chloroform; S3, adding PBS for hydration, and performing ultrasonication to obtain liposomes; and S4, adding EDC/NHS to the liposome solution obtained for reaction for 15 min, then adding mRNA, and stirring the mixed solution to obtain a bionic virus nanovaccine. The prepared PEI-LNPs are used for delivering an mRNA vaccine and transfecting stem cells, wherein through a lipid PEI derivative library synthesized based on short-branched PEI with a variable length and hydrophobic tail substitution ratio, short-branched PEI can form a stable complex with the mRNA vaccine.
    Type: Application
    Filed: July 12, 2022
    Publication date: August 31, 2023
    Applicants: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) Limited
    Inventors: Bin ZHENG, Yulin CAO, Tingting HUA, Shixiang CHENG
  • Publication number: 20230270779
    Abstract: An exosome hydrogel for treating severe respiratory diseases is provided and includes a temperature-sensitive hydrogel and an exosome; wherein the temperature-sensitive hydrogel is PLGA-PEG-PLGA. According to the present invention, PLGA-PEG-PLGA generates a hydrogel exosome through a phase transition at a body temperature, and the hydrogel stays in lungs for a longer time than common exosomes, thereby making the exosome remain at an infection site and producing a better therapeutic effect. The exosome hydrogel features high safety, is suitable for promotion, and has good potential in medical treatment.
    Type: Application
    Filed: March 4, 2022
    Publication date: August 31, 2023
    Applicants: Tangyi Holdings(Shenzhen) Limited, Healthina Stem Cell Industry Platform (Tianjin) Limited
    Inventors: Bin ZHENG, Yulin CAO, Tingting HUA, Shixiang CHENG
  • Publication number: 20230256081
    Abstract: A method for preparing an atomizing SARS-CoV-2 nanovaccine includes the followings steps: mimicking a structure of SARS-COV-2 with receptor binding domains (RBDs) of SARS-COV-2, by taking Poly(I:C) mimicking viral genetic materials as an immunoadjuvant, and electronegative liposomes that enter pulmonary macrophages efficiently as a viral capsid structure; adding a catalyst and an RBD antigen protein to a liposome solution, linking the antigen protein to a liposome surface, and obtaining a bionic virus nanovaccine after purification and freeze-drying treatment. Compared with conventional intramuscular and subcutaneous inoculation, the SARS-CoV-2 vaccine of the present invention features strong mucosal protection effect, high safety, extensive application, and excellent potential.
    Type: Application
    Filed: April 14, 2022
    Publication date: August 17, 2023
    Applicants: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) Limited
    Inventors: Bin ZHENG, Yulin CAO, Tingting HUA, Shixiang CHENG
  • Publication number: 20230071574
    Abstract: The present invention discloses an anti-hair loss and hair growth integrated core-shell microneedle patch, comprising a backing and a core-shell microneedle array attached to one side of the backing, the core-shell microneedle array comprises a plurality of microneedles arranged on the backing to form an array, each microneedle comprises a shell substrate material and an internal core, and the shell substrate material is loaded with nano-enzyme for removing excessive active oxygen.
    Type: Application
    Filed: October 18, 2021
    Publication date: March 9, 2023
    Inventors: Bin Zheng, Yulin Cao, Bowen Li, Wei Sun, Shixiang Cheng
  • Publication number: 20230065910
    Abstract: The present invention discloses a nano-armored single cell product, comprising a liposome and probiotics encapsulated by the liposome, wherein the probiotics are fermented to produce gamma-aminobutyric acid (GABA) that alleviates the activation of an inflammatory response in substantia nigra inducedin a MPTP induced PD model, thus mitigating an inflammatory injury to dopaminergic neurons in substantia nigra and having a neuroprotective effect; encapsulation of the probiotics by the liposome can protect the probiotics from strong acids and digestive enzymes in gastric acid.
    Type: Application
    Filed: October 18, 2021
    Publication date: March 2, 2023
    Inventors: Bin Zheng, Yulin Cao, Wei Sun, Qinglu Guo, Shixiang Cheng